Antazoline: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
<div style="float: right;"> | <div style="float: right;"> | ||
[[File:Antazoline.png|thumb|none|400px|This image is provided by the National Library of Medicine.]]</div> | [[File:Antazoline.png|thumb|none|400px|This image is provided by the National Library of Medicine.]]</div> | ||
__NOTOC__ | __NOTOC__ | ||
{{SI}} | {{SI}} | ||
{{CMG}} | {{CMG}} | ||
==Overview=='''Antazoline''' is a 1st generation [[antihistamine]] that also [[anticholinergic]] properties used to relieve [[nasal congestion]] and in [[eye drop]]s, usually in combination with [[naphazoline]], to relieve the symptoms of [[allergy|allergic]] [[conjunctivitis]].<ref>{{cite journal |journal = Am J Ophthalmol. |year = 1980 |volume =90 |pages = 254–7 |title = Effects of topically applied ocular decongestant and antihistamine |author = Abelson MB, Allansmith MR, Friedlaender MH. |pmid=7425039 |issue=2}}</ref> | ==Overview== | ||
'''Antazoline''' is a 1st generation [[antihistamine]] that also [[anticholinergic]] properties used to relieve [[nasal congestion]] and in [[eye drop]]s, usually in combination with [[naphazoline]], to relieve the symptoms of [[allergy|allergic]] [[conjunctivitis]].<ref>{{cite journal |journal = Am J Ophthalmol. |year = 1980 |volume =90 |pages = 254–7 |title = Effects of topically applied ocular decongestant and antihistamine |author = Abelson MB, Allansmith MR, Friedlaender MH. |pmid=7425039 |issue=2}}</ref> | |||
== References == | == References == | ||
| Line 15: | Line 12: | ||
{{Nasal preparations}} | {{Nasal preparations}} | ||
{{Antihistamines}} | {{Antihistamines}} | ||
[[Category:H1 receptor antagonists]] | [[Category:H1 receptor antagonists]] | ||
[[Category:Imidazolines]] | [[Category:Imidazolines]] | ||
[[Category:Drug]] | [[Category:Drug]] | ||
Latest revision as of 12:50, 8 April 2015
|
WikiDoc Resources for Antazoline |
|
Articles |
|---|
|
Most recent articles on Antazoline |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Antazoline at Clinical Trials.gov Clinical Trials on Antazoline at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Antazoline
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Antazoline Discussion groups on Antazoline Patient Handouts on Antazoline Directions to Hospitals Treating Antazoline Risk calculators and risk factors for Antazoline
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Antazoline |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Antazoline is a 1st generation antihistamine that also anticholinergic properties used to relieve nasal congestion and in eye drops, usually in combination with naphazoline, to relieve the symptoms of allergic conjunctivitis.[1]